Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00208 |
| Species: | Homo sapiens |
| Position : | chr2:46573123-46594333 |
| Year: | 2022 |
| Title: | A pleiotropic hypoxia-sensitive EPAS1 enhancer is disrupted by adaptive alleles in Tibetans |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 36417539 |
| MONDO: | MONDO:0008315 |
| Tissue: | Prostate |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | Human prostate cancer cell |
| CVCL ID: | |
| Cell Type: | prostate carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, ATAC-seq, 3C-seq |
| Low Throughput Method: | CRISPR Knockout, Luciferase Reporter Assay |
| Target gene : | EPAS1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|